The first and only sphingosine 1-phosphate (S1P) receptor modulator approved for the treatment of moderately to severely active ulcerative colitis (UC) in adults1
ANOTHER DAY IS DAWNING IN THE CONTROL OF UC
Now many of your patients can choose another path forward before biologics.1a ZEPOSIA delivers: